DGX
Quest Diagnostics Incorporated · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares -13.3% ·
flujo de acciones +2.5% ·
nuevas posiciones netas -15.4%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 154 | +1 | 78.04M | $16.53B | +7 | −6 |
| Q1 2026 | 156 | -1 | 76.50M | $14.98B | +4 | −6 |
| Q4 2025 | 156 | +4 | 87.42M | $15.15B | +5 | — |
| Q3 2025 | 16 | -1 | 54.97M | $10.47B | — | −2 |
| Q2 2025 | 15 | -3 | 44.54M | $8.00B | — | −3 |
| Q1 2025 | 15 | +2 | 17.80M | $3.01B | +3 | −1 |
| Q4 2024 | 13 | -2 | 18.37M | $2.77B | — | −2 |
| Q3 2024 | 14 | -1 | 12.70M | $1.97B | — | −1 |
| Q2 2024 | 15 | — | 9.75M | $1.33B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.49M | +42.5% | $828.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.49M | +42.5% | $828.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 5.22M | — | $787.72M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.69M | +2.8% | $404.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 2.69M | +2.8% | $404.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.78M | -23.5% | $269.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (pasivo) | 1.27M | -1.8% | $191.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 796.08K | -20.4% | $120.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 653.77K | +302.8% | $98.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 194.43K | -27.8% | $29.33M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 146.59K | -44.3% | $22.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 79.37K | +2570.6% | $11.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 21.89K | -75.3% | $3.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 21.89K | -0.7% | $3.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 1.34K | -28.1% | $202,303 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Citadel Advisors | $116.15M | era 0.1% |
| Renaissance Technologies | $5.92M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 41.40K acciones, $8,113 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.